Welcome to Peptide Card of AntiTbPdb
| This page displays user query in tabular form. |
APKGVQGPNG details |
| Primary information | |
|---|---|
| ID | antitb_1949, |
| Name | 28050849 |
| N-Terminal modification | YD-1 |
| C-Terminal Modification | APKGVQGPNG |
| Chemical Modification | Free |
| Linear/Cyclic | Amidation |
| Length | None |
| Chirality | Linear |
| Nature | 10 |
| Source | L |
| Species | Natural |
| Strain | Derived from Bacillus amyloliquefaciens CBSYD1 |
| Inhibition Concentration | Mycobacterium smegmatis |
| In Vitro/ In vivo | Mycobacterium smegmatis ATCC 9341 |
| Cell Line | MIC = 8 μg/ml |
| Inhibition Concentration | In vitro |
| Sequence | 2017 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | Cell wall pore formation |
| PMID | NA |
| Year of Publication | Antibacterial against gram negative such as Alcaligenes faecalis ATCC 1004, Salmonella Typhimurium KCTC 1925 etc and gram positive bacteria such as Enterococcus faecalis ATCC 29212, Micrococcus luteus ATCC 9341, Staphylococcus aureus KCTC 1928 |
| Tertiary Structure (Technique) | Not Predicted), |